期刊文献+

临床药师对心血管疾病患者进行华法林药学监护切入点的探讨 被引量:9

Key Points for Clinical Pharmacists to Develop Pharmaceutical Care for Cardiovascular Patients Receiving Warfarin
下载PDF
导出
摘要 目的:探讨临床药师为心血管疾病患者应用华法林实施药学监护的切入点。方法:通过分析影响华法林抗凝作用的因素及患者在华法林抗凝治疗中容易出现的问题开展药学服务,指导其规范使用抗凝药华法林。结果与结论:影响华法林抗凝作用的因素较多,药师应积极开展合理有效的药学服务,以避免不良事件发生,对提高患者生活质量具有重要意义。 OBJECTIVE: To study the key points for clinical pharmacists to develop pharmaceutical care for cardiovascular patients treated with warfarin.METHODS: Through analyzing the factors affecting the anticoagulant efficacy of warfarin and problems likely occurred during the anticoagulant treatment,we developed pharmaceutical care for patients by providing them with guidance about the standard use of warfarin.RESULTS CONCLUSION: The anticoagulant efficacy of warfarin was influenced by many factors.It is important for pharmacists to develop active,reasonable and effective pharmaceutical care to avoid the occurrence of adverse events,which is of great importance for improving patients’quality of life.
作者 任汉学
出处 《中国医院用药评价与分析》 2011年第4期378-380,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 临床药师 华法林 药学监护 Clinical pharmacists Warfarin Pharmaceutical care
  • 相关文献

参考文献9

二级参考文献66

共引文献311

同被引文献70

  • 1赵洁,李超鹏,张之慧.心房颤动患者华法林抗凝治疗依从性调查分析[J].农垦医学,2014,36(1):68-71. 被引量:3
  • 2范明霞,舒文琳,谢黎崖,邵志宇.电解质对全肠外营养液稳定性的影响考察[J].中国药房,2005,16(23):1824-1826. 被引量:12
  • 3卫生部合理用药专家委员会.中国医师药师临床用药指南[M].第1版.重庆:重庆出版社,2009:141.
  • 4Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke pre- vention in atrial fibrillation: how well do random izedtrials translate into clinical practice [ J ]. JAMA, 2003,290 (20) : 2 685 - 2 692.
  • 5Rieder MJ, Riener AP, Gage BF, et al. Effect of VKORC1 haplotypes transcriptional regulation and warfarin dose[J]. N Engl J Med, 2005, 352(22) :2 285 -2 293.
  • 6Thomson Micromedex Healthcare Series [ CP/DB ]. Colorado (USA) : The Thomson Corporation : 2007.
  • 7HEIMARKL D, WIENKERS L, KUNZE K,et al.The mecha-nism of the interaction between amiodarone and warfarin in hu-mans [JJ.Clin Pharmacol Ther, 1992,51(4):398-407.
  • 8SchulmanS , Parpia S , Stewart C, Rudd -Scott L, Julian J,Levine M . Warfarin dose assessment every 4 weeks versus every12 weeks in patients with stable international normalized ratios: arandomized trial [J].Ann Intern Med,2011,155( 10):653-659.
  • 9Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J]. Europace, 2006,8 : 651-745.
  • 10Grisaru-Soen G, Paret G, Yahav D, et al. Nosocomial infectionsin pediatric cardiovascular surgery patientst a 4-year survey [J]. Pediatr Crit Care Med, 2009, 10(2) : 202-206.

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部